Company Filing History:
3 out of 60 
1 out of 410 
Years Active: 2019-2025
Title: Innovations of Jennifer Furman
Introduction
Jennifer Furman is an accomplished inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins aimed at addressing metabolic disorders. With a total of 4 patents to her name, her work is paving the way for innovative treatments.
Latest Patents
Among her latest patents is the invention of glucagon-like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and their uses. This patent outlines methods for utilizing GLP1-GDF15 fusion proteins to reduce food intake and to prevent, treat, or ameliorate diseases such as obesity, type 2 diabetes, metabolic syndrome, insulin resistance, and dyslipidemia. The fusion protein comprises a GLP1 or GLP1 variant peptide, a first linker peptide, a serum albumin protein, a second linker peptide, and a GDF15 protein. This innovative approach has the potential to revolutionize treatment options for patients suffering from these conditions.
Career Highlights
Jennifer has worked with notable companies in the biotechnology sector, including Janssen Sciences Ireland Unlimited Company and Janssen Biotech, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects.
Collaborations
Jennifer has collaborated with talented individuals such as Chichi Huang and Xiefan Lin-Schmidt. These partnerships have contributed to her success and the advancement of her innovative work.
Conclusion
Jennifer Furman is a pioneering inventor whose work in fusion proteins is making a significant impact in the field of biotechnology. Her contributions are essential in the fight against metabolic disorders, and her patents reflect her dedication to innovation.